The Relationship Between Mortality and Leuko-Glycemic Index in Coronary Care Unit Patients (MORCOR-TURK LGI)

Year 2024, Volume: 51 Issue: 3, 315 - 324, 19.09.2024

Muammer Karakayalı , Oğuz Kılıç , Mürsel Şahin , Saban Kelesoglu İshak Yilmaz Ramazan Duz , Ahmet Seyda Yılmaz , İbrahim Ersoy

https://doi.org/10.5798/dicletip.1552382

Abstract

Introduction&Objective: Identifying high-risk patients with a poor prognosis in coronary care unit (CCU) patients can assist physicians in providing optimal care and implementing preventive strategies. Leuko-glycaemic index (LGI), synthesized by multiplying the blood glucose level by the leukocyte count, has gained popularity in risk stratification of myocardial infarction patients. In this context, this study was carried out to investigate the relationship between LGI assessed at admission and in-hospital mortality in CCU patients.
Methods: This is a multi-center, cross-sectional and observational study. (MORCOR-TURK LGI: Mortality Predictors in Coronary Care in Turkey, ClinicalTrials.gov number NCT05296694). The population of this study consisted of 2917 consecutive patients admitted to the CCU. Blood samples were collected into serum separator tubes in the immediate admission to the CCU. LGI was calculated by multiplying both values and dividing them by a thousand. LGI units were expressed in mg/dl. mm³. The sample was divided into two groups based on the LGI cut-off value of 1.23. Logistic regression analysis was used to find the significant predictors of mortality. Receiver operating characteristics (ROC) curve was to find out the cut-off value of LGI. A p value less than 0.05 was considered to be statistically significant in all analyses.
Results: Univariable logistic regression analysis revealed that age, heart failure (HF), LGI, coronary artery disease, hypertension, diabetes mellitus and atrial fibrillation are clinically and statistically significant predictors. Further analysis of these variables using the multivariable logistic regression analysis indicated that age (Odds Ratio [OR]: 1.040, 95% confidence interval [CI]: 1.017-1.063; p=0.001), HF (OR: 2.426, 95% CI: 1.419-4.149; p:0.001) and LGI (OR: 1.349, 95% CI: 1.176-1.549; p<0.001), were independent predictors for the development of in-hospital mortality in CCU. LGI score optimal cut-off value of >3.72 predicted in-CCU mortality with 95.56% sensitivity and 49.19% specificity ([AUC]: 0.659 [95% CI: 0.641–0.676, p<0.001]).
Conclusion: LGI, a simple and inexpensive index, was associated with in-hospital mortality in CCU patients. Aggressive treatment strategies should be adopted for these patients with higher LGI upon admission. Prospective studies are needed to clarify the prognostic relevance of LGI and CCU patients' mortality in terms of future cardiovascular events.

Keywords

leuko-glycemic index, in-hospital mortality, critical care, coronary care unit.

References

• 1.Roth GA, Mensah GA, Johnson CO, et al. GlobalBurden of Cardiovascular Diseases and Risk Factors,1990-2019: Update From the GBD 2019 Study. J AmColl Cardiol. 2020;76(25):2982-3021.
• 2.Hodas R, Polexa ȘA, Rareș M, & Benedek T. Coronary Computed Tomography Angiography for Assesment ofStable Coronary Artery Disease–a Cost-effectivenessPerspective. Journal of Interdisciplinary Medicine.2021;6(1):37-42.
• 3.Haji Aghajani M, Toloui A, Ahmadzadeh K, MadaniNeishaboori A, Yousefifard M. Premature CoronaryArtery Disease and Plasma Levels of Interleukins; aSystematic Scoping Review and Meta-Analysis. ArchAcad Emerg Med. 2022;10(1):51.
• 4.Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, et al. Endothelial Dysfunction, Inflammationand Coronary Artery Disease: Potential Biomarkersand Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):3850.
• 5.Sloman JG, Julian D. History and future of thecoronary care unit. In:Thompson PL, editor. CoronaryCare Manual. London: Churchill Livingstone, 1997:3–6.
• 6.Zimmerman JE, Kramer AA, McNair DS, et al. AcutePhysiology and Chronic Health Evaluation (APACHE)IV: hospital mortality assessment for today's criticallyill patients. Crit Care Med. 2006;34:1297-310.
• 7.Vincent JL, Moreno R, Takala J, et al. The SOFA(Sepsis-related Organ Failure Assessment) score todescribe organ dysfunction/failure. On behalf of theWorking Group on Sepsis-Related Problems of theEuropean Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
• 8.Jentzer JC, Bennett C, Wiley BM, et al. PredictiveValue of the Sequential Organ Failure AssessmentScore for Mortality in a Contemporary CardiacIntensive Care Unit Population. J Am Heart Assoc.2018;7(6):e008169.
• 9.Chen S, Zhang S, Luan H, et al. Correlation betweenextended leukocyte differential count and coronaryartery disease. J Cardiovasc Pharmacol.2018;71(6):359-66.
• 10.Quiroga W, Conci E, Zelaya F, et al. Estratificacióndel riesgo en el infarto agudo de miocardio según elíndice leucoglucémico.¿ El Killip-Kimball delaboratorio. Rev Fed Arg Cardiol. 2010;39(1):29-34.
• 11.Qi LY, Liu HX, Cheng LC, et al. Prognostic value ofthe leuko-glycemic index in acute myocardialinfarction patients with or without diabetes. Diabetes,Diabetes Metab Syndr Obes. 2022;15:1725-36.
• 12.Seoane LA, Burgos L, Espinoza JC, et al. PrognosticValue of the Leuko-Glycaemic Index in the Postoperative Period of Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2021;36(4):484-91.
• 13.León-Aliz E, Moreno-Martínez FL, Pérez-FernándezGA, Vega-Fleites LF, Rabassa-López-Calleja MA.[Leukoglycemic index as an in-hospital prognosticmarker in patients with ST-segment elevationmyocardial infarction]. Clin Investig Arterioscler.2014;26(4):168-75.
• 14.Mittal SH, Goel D. Mortality in ischemic strokescore: A predictive score of mortality for acuteischemic stroke. Brain Circ. 2017;3(1):29-34.
• 15.Ibanez B, James S, Agewall S, et al. 2017 ESCguidelines for the management of acute myocardialinfarction in patients presenting with ST-segmentelevation: The Task Force for the management of acutemyocardial infarction in patients presenting with ST-segment elevation of the European Society ofCardiology (ESC). Eur Heart J. 2018;39:119-77.
• 16.Collet JP, Thiele H, Barbato E, et al. 2020 ESCGuidelines for the management of acute coronarysyndromes in patients presenting without persistentST-segment elevation: The Task Force for themanagement of acute coronary syndromes in patientspresenting without persistent ST-segment elevation ofthe European Society of Cardiology (ESC). Europeanheart journal. 2021;42(14):1289-1367.
• 17.McDonagh TA, Metra M, Adamo M, et al. 2021 ESCGuidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force forthe diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)With the special contribution of the Heart FailureAssociation (HFA) of the ESC. European heart journal.2021;42(36):3599-3726.
• 18.Mach F, Baigent C, Catapano AL, et al. 2019ESC/EAS Guidelines for the management ofdyslipidaemias: lipid modification to reducecardiovascular risk: the Task Force for themanagement of dyslipidaemias of the EuropeanSociety of Cardiology (ESC) and EuropeanAtherosclerosis Society (EAS). European heart journal.2020;41(1):111-88.
• 19.Mitchell C, Rahko PS, Blauwet LA, et al. Guidelinesfor performing a comprehensive transthoracicechocardiographic examination in adults:recommendations from the American Society ofEchocardiography. J Am Soc Echocardiogr. 2019;32:1-64.
• 20.Zhang L, Wang Z, Xu F, et al. Effects of stresshyperglycemia on short-term prognosis of patientswithout diabetes mellitus in coronary care unit.Frontiers in cardiovascular medicine. 2021;8:683932.
• 21.Terlecki M, Bednarek A, Kawecka-Jaszcz K,Czarnecka D, Bryniarski L. Acute hyperglycaemia andinflammation in patients with ST segment elevationmyocardial infarction. Kardiol Pol. 2013;71(3):260–67.
• 22. Hirschson Prado A, Higa C, Merlo P, et al. Prognostic Value of the leuko-glycemic Index in Acute MyocardialInfarction. results from the SCAr Multicenter registry.Rev Argent Cardiol. 2014;82:500-5.
• 23.Rodriguez-Jiménez A, Fardales-Rodríguez R,Toledo-Rodríguez E, Quintana Cañizares. Índice leuco-glucémico como factor pronóstico tras un infartoagudo de miocardio con elevación del segmentoST.Revista Finlay. 2019;9(2):97-107.
• 24.Kahraman F, Durmus HI, & Kilic O. LeukoglycemicIndex may be a Unique Parameter to Predict Mortalityin Patients with Acute Myocardial Infarction: SingleOperator Experience. Sakarya Tıp Dergisi.2023;13:118-23.
• 25.Campanile A, Castellani C, Santucci A, et al.Predictors of in-hospital and long-term mortality inunselected patients admitted to a modern coronarycare unit. Journal of Cardiovascular Medicine.2019;20(5):327-34.
• 26.Johansson I, Joseph P, Balasubramanian K, et al.Health-related quality of life and mortality in heartfailure: the global congestive heart failure study of 23000 patients from 40 countries. Circulation.2021;143:2129-42.
• 27.Sadeghi R, Roshdi Dizaji S, Vazirizadeh-MahabadiM, Sarveazad A, Forouzannia SA. Prognostic Value ofThe Leuko-Glycemic Index in Acute MyocardialInfarction; a Systematic Review and Meta-Analysis.Arch Acad Emerg Med. 2023;11(1):e25.
• 28.Yurdam FS, & Kış M. Association between coronaryartery lesion severity in coronary computedtomography angiography and hemoglobin A1c innondiabetic patients with chronic coronary syndrome.Cardiovascular Surgery and Interventions.2023;10(1):1-7.